Page 14 of 89
Previous Page     Next Page        Smaller fonts | Larger fonts     Go back to the flash version

14

nanotimes

Companies Facts

with two-position output in two directions for use in zoom lever control of mobile devices such as compact digital cameras and di- gital camcorders. Mass production commenced in February 2012.

A

http://www.alps.com/products/e/npv_product/120301_ SSCQ/SSCQ_E.PDF

T

he Board of Directors of AMCOL International Corporation (NYSE: ACO) has declared a quar-

terly dividend of $0.18 a share for the first quarter of 2012. The first quarter dividend is payable on April 10, 2012 to shareholders of record as of March 6, 2012.

http://www.amcol.com

1.0 GHz to 18.0 GHz highpass / low- pass diplexer, Bias-T from its CMT Filters product group. The CMD837, 1.0 GHz to 18.0 GHz Bias-T,

A

PI Technologies Corp. (NASDAQ: ATNY) announced the availability of its new CMD837,

LPS ELECTRIC EUROPE GmbH has developed the SSCQ Series compact detector switch

is an ideal solution when RF modulation or DC injec- tion is essential.

http://apitech.com

velopment programs in oncology and obesity, an- nounced financial results for its fiscal 2012 first quarter ended December 31, 2011. For the quarter ended December 31, 2011, Arrowhead reported revenues of $23,958, compared to revenue of $296,139 in the quarter ended December 31, 2010. Total operating expenses for the quarter ended December 31, 2011 were $4.1 million, compared to $3.6 million during the quarter ended December 31, 2010.

A

Net loss attributable to Arrowhead for the quarter en- ded December 31, 2011 was $2.5 million, or $0.25 per share based on 10,121,069 weighted average shares outstanding. This compares with a net loss attributable to Arrowhead of $1.4 million, or $0.20 per share based on 7,177,941 weighted average shares outstanding, for the quarter ended December 31, 2010.

The Company‘s net cash used in operations for the quarter ended December 31, 2011 was $2.7 million, compared with $0.9 million for the quarter ended December 31, 2010. Cash provided by investing activities was $0.5 million, primarily due to cash received from the sale of investments. Cash provided by financing activities was $1.4 million, primarily due to the issuanc

rrowhead Research Corporation (NASDAQ: ARWR), a nanomedicine company with de-

12-02 :: February/March 2012

Previous arrowPrevious Page     Next PageNext arrow        Smaller fonts | Larger fonts     Go back to the flash version
1  |  2  |  3  |  4  |  5  |  6  |  7  |  8  |  9  |  10  |  11  |  12  |  13  |  14  |  15  |  16  |  17  |  18  |  19  |  20  |  21  |  22  |  23  |  24  |  25  |  26  |  27  |  28  |  29  |  30  |  31  |  32  |  33  |  34  |  35  |  36  |  37  |  38  |  39  |  40  |  41  |  42  |  43  |  44  |  45  |  46  |  47  |  48  |  49  |  50  |  51  |  52  |  53  |  54  |  55  |  56  |  57  |  58  |  59  |  60  |  61  |  62  |  63  |  64  |  65  |  66  |  67  |  68  |  69  |  70  |  71  |  72  |  73  |  74  |  75  |  76  |  77  |  78  |  79  |  80  |  81  |  82  |  83  |  84  |  85  |  86  |  87  |  88  |  89